Supplemental material
OncoImmunology
Volume 8, 2019 - Issue 11
Open access
6,170
Views
60
CrossRef citations to date
0
Altmetric
Original research
Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors
Ioannis KaffesDepartment of Pediatrics, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA;Department of Cellular Neurosciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, GermanyView further author information
, Frank SzulzewskyDepartment of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USAView further author information
, Zhihong ChenDepartment of Pediatrics, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA;Discovery and Developmental Therapeutics Program, Winship Cancer Institute, Emory University, Atlanta, GA, USA
https://orcid.org/0000-0001-7403-7015View further author information
Cameron J. HertingDepartment of Pediatrics, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USAView further author information
, Ben GabanicDepartment of Pediatrics, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USAView further author information
, José E. Velázquez VegaDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USAView further author information
, Jennifer SheltonDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USAView further author information
, Jeffrey M. SwitchenkoDepartment of Biostatistics and Bioinformatics, Winship Cancer Institute, Emory University, Atlanta, GA, USAView further author information
, James L. RossDepartment of Pediatrics, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USAView further author information
, Leon F. McSwainDepartment of Pediatrics, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USAView further author information
, Jason T. HuseDepartments of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
, Bengt WestermarkDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, SwedenView further author information
, Sven NelanderDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, SwedenView further author information
, Karin Forsberg-NilssonDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, SwedenView further author information
, Lene UhrbomDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, SwedenView further author information
, Naga Prathyusha MaturiDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, SwedenView further author information
, Patrick. J. CiminoDepartment of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;Department of Pathology, University of Washington, Seattle, WA, USAView further author information
, Eric C. HollandDepartment of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USAView further author information
, Helmut KettenmannDepartment of Cellular Neurosciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, GermanyView further author information
, Cameron W. BrennanDepartment of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York City, NY, USAView further author information
, Daniel J. BratDepartment of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USACorrespondence[email protected]
View further author information
& View further author information
Dolores HambardzumyanDepartment of Pediatrics, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA;Discovery and Developmental Therapeutics Program, Winship Cancer Institute, Emory University, Atlanta, GA, USACorrespondence[email protected]
https://orcid.org/0000-0003-1975-4665View further author information
Article: e1655360
|
Received 03 Apr 2019, Accepted 09 Aug 2019, Published online: 22 Aug 2019
Related Research Data
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.
Source:
Elsevier Inc.
Tregs in gliomas - The jury is still out
Source:
Oxford University Press (OUP)
Immune Microenvironment in Glioblastoma Subtypes.
Source:
Frontiers Media S.A.
Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma.
Source:
Springer Science and Business Media LLC
Regulatory T cells are not a strong predictor of survival for patients with glioblastoma
Source:
Oxford University Press (OUP)
Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class
Source:
The University of North Carolina at Chapel Hill University Libraries
The role of microglia and macrophages in glioma maintenance and progression
Source:
Springer Science and Business Media LLC
Widespread activation of microglial cells in the hippocampus of chronic epileptic rats correlates only partially with neurodegeneration.
Source:
Springer Science and Business Media LLC
MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma
Source:
Proceedings of the National Academy of Sciences
Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis
Source:
Impact Journals (U.S.A.)
Microglia or macrophages in GBM
Source:
Wiley
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Source:
American Association for Cancer Research (AACR)
Intravital 2-photon imaging reveals distinct morphology and infiltrative properties of glioblastoma-associated macrophages.
Source:
Proceedings of the National Academy of Sciences
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
Source:
Elsevier BV
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
Source:
American Association for Cancer Research (AACR)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Source:
Elsevier BV
PD-L1 expression and prognostic impact in glioblastoma.
Source:
Oxford University Press (OUP)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Source:
American Association for Cancer Research (AACR)
Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling
Source:
Oxford University Press (OUP)
Current state of immunotherapy for glioblastoma
Source:
Nature Publishing Group
Increased Microglia/Macrophage Gene Expression in a Subset of Adult and Pediatric Astrocytomas
Source:
Public Library of Science (PLoS)
Part 2: Studies of the macrophage content of human brain tumors
Source:
Journal of Neurosurgery Publishing Group (JNSPG)
Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas
Source:
American Association for Cancer Research (AACR)
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.
Source:
HAL CCSD
Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates
Source:
Springer Nature
The 2007 WHO Classification of Tumours of the Central Nervous System
Source:
Springer Nature
Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
Source:
American Association for Cancer Research (AACR)
The 2007 WHO Classification of Tumours of the Central Nervous System
Source:
Springer Nature
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal
Source:
American Association for the Advancement of Science (AAAS)
1919 Río-Hortega Papers on Microglia
Source:
Wiley
Prognostic significance and mechanism of Treg infiltration in human brain tumors.
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.